Benefits of CGM

How CGM Works

Continuous glucose monitoring (CGM) systems provide a glucose reading every five minutes, 288 times per day, giving you insights that fingersticks cannot match.

Small Sensor

A discreet sensor located just underneath your skin measures glucose levels.

Transmitter

Glucose data is sent wirelessly to an insulin pump* and compatible smart device via Bluetooth technology.

Insulin Pump Integration

The t:slim X2 insulin pump displays the current glucose reading from the CGM system plus a trend arrow and trend line. This makes it easy to see where you are now, spot trends, and catch high and low glucose events before they happen. When combined with current insulin on board, it helps you make informed treatment decisions.

Test Yourself

Even if you test your blood sugar as often as recommended, there’s a big part of the picture you’re not seeing with fingersticks alone.

What would you do at 102?

If your glucose continues to fall at the current rate, you could be below 60 mg/dL in the next 15 minutes.

Your glucose could move up or down by 15 mg/dL over the next 15 minutes, but you are holding steady.

If your glucose continues to rise at the current rate, you could be close to 150 mg/dL in the next 15 minutes.

Answer

When paired with Dexcom G6 CGM, the t:slim X2 insulin pump can help you visualize CGM trends so you can make real-time decisions based on real-time data. Plus, the t:slim X2 pump with Control-IQ technology has been shown to help simplify diabetes management by protecting from highs and lows while increasing time in range.^†

Zero Fingersticks

Known for its exceptional accuracy and performance, Dexcom G6 CGM lets you make treatment decisions without pricking your finger for calibration or mealtime dosing. The t:slim X2 insulin pump is the only available pump that integrates with Dexcom CGM.^‡

What’s next?

Whether you're ready to get a pump, or looking to check insurance coverage, you’ll find everything you need here.

Let's Get Started

Responsible Use of Control‑IQ Technology

Even with advanced systems such as the t:slim X2 insulin pump with Control-IQ technology, you are still responsible for actively managing your diabetes. Control-IQ technology does not prevent all high and low blood glucose events. The system is designed to help reduce glucose variability, but it requires your accurate input of information, such as meals and periods of sleep or exercise. Control-IQ technology will not function as intended unless you use all system components, including your CGM, infusion sets and pump cartridges, as instructed. Importantly, the system cannot adjust your insulin dosing if the pump is not receiving CGM readings. Because there are situations and emergencies that the system may not be capable of identifying or addressing, always pay attention to your symptoms and treat according to your healthcare provider's recommendations.

* Dexcom CGM sold separately.

† As measured by CGM.

‡ Zero fingersticks required when using the t:slim X2 pump with Dexcom G6 CGM integration. If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

Important Safety Information

RX ONLY. The t:slim X2 pump and Control-IQ technology are intended for single patient use. The t:slim X2 pump and Control-IQ technology are indicated for use with U-100 insulin only. t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The t:slim X2 pump is indicated for use in individuals six years of age and greater. Control-IQ technology: Control-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater.

Warning: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.

Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of the t:slim X2 pump and Control-IQ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The t:slim X2 pump, and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.

Select Country

Benefits of CGM

How CGM Works

Small Sensor

Transmitter

Insulin Pump Integration

Test Yourself

What would you do at 102?

Answer

Zero Fingersticks

Download Today

Free Virtual Pump Demo

What’s next?

Responsible Use of Control‑IQ Technology

About Tandem

Disclosures

Newsletter Signup